Iberian Registry of Ocular Syphilis (IBERSOS) report 1: epidemiology, clinical spectrum and treatment outcomes of ocular syphilis in the Iberian Peninsula
Authors:
Open Access
- 6 March 2026
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (10) , 1189-1194
Abstract
Purpose The Iberian Registry of Ocular Syphilis aims to describe the epidemiology, clinical manifestations and treatment outcomes of ocular syphilis in Spain and Portugal. This re-emerging condition, associated with rising global syphilis rates and HIV coinfection, presents with diverse ocular and systemic features. The study seeks to fill knowledge gaps regarding incidence, presentation and therapeutic response. Methods This multicentre, observational cohort study includes patients aged ≥18 years with newly diagnosed ocular syphilis confirmed by treponemal and nontreponemal serological tests. Conducted across 23 centres, data collection followed routine clinical practice and included demographics, ocular/systemic findings, treatment regimens and outcomes at 3–6 months post-treatment. Results In the first year, 41 patients met the inclusion criteria, of whom 39 consented to participate in the registry, with an incidence of 0.57 cases per 100 000 persons/year. Most were male (94.9%), especially men who have sex with men (66.7%) and HIV coinfection (20.5%). Bilateral ocular involvement was observed in 64.1% of patients, with anterior segment inflammation in 64.1%, vitritis in 53.8%, retinal or choroidal involvement in 69.2% and optic nerve involvement in 59.0%. Systemic syphilis stage included primary (7.7%), secondary (25.6%) and tertiary or quaternary (15.4%). Treatment was initiated after a mean of 6.2±9.3 weeks after the onset of symptoms, and 2.6±6.0 weeks after the initial presentation at the hospital. Intravenous penicillin G was used in 65.8%, and 61.3% achieved a four-fold titre reduction in the reaginic test at the final visit (3 to 6 months after antibiotic therapy). Final visual acuity improved to 0.17 LogMAR (pConclusions Ocular syphilis in the Iberian Peninsula shows a wide clinical spectrum and frequent posterior segment involvement. Most patients achieved favourable serological and visual outcomes. These findings support the effectiveness of standard therapies and highlight the need for early diagnosis, especially in high-risk populations.Keywords
Funding Information
- Roche (No specific grant or award number applies.)
- Sociedad Española de Inflamación Ocular (No specific grant or award number applies.)
This publication has 22 references indexed in Scilit:
- Ocular Syphilis: The Resurgence of an Old Disease Experience of a Tertiary Centre in PortugalOcular Immunology and Inflammation, 2024
- Influence of gender on clinical presentation, management practices and outcomes of ocular syphilisScientific Reports, 2024
- Clinical features and incidence of visual improvement following systemic antibiotic treatment in patients with syphilitic uveitisScientific Reports, 2022
- Ocular syphilisSurvey of Ophthalmology, 2022
- Ocular Syphilis: Experience over 11 Years at a German Ophthalmology Reference CentreOcular Immunology and Inflammation, 2021
- The Modern Epidemic of SyphilisNew England Journal of Medicine, 2020
- Clinical Manifestations and Ophthalmic Outcomes of Ocular Syphilis at a Time of Re-Emergence of the Systemic InfectionScientific Reports, 2018
- SyphilisNature Reviews Disease Primers, 2017
- Ocular Syphilis: An UpdateOcular Immunology and Inflammation, 2017
- Factors Determining Serologic Response to Treatment in Patients with SyphilisClinical Infectious Diseases, 2009